Keyphrases
Esophageal Carcinoma
100%
Epithelial-mesenchymal Transition
100%
Esophageal Epithelium
100%
Serum Amyloid A
100%
Integrin
66%
Esophageal Squamous Cell Carcinoma
46%
Esophagus
33%
N-cadherin
33%
Esophageal Squamous Carcinoma Cell
26%
Mesenchymal-epithelial Transition Factor
20%
Carcinoma Cell Lines
20%
Tumor Invasion
20%
Normal Epithelium
20%
Transforming Growth Factor-β
13%
Epithelial Cells
13%
Tumor Tissue
13%
Expression Pattern
13%
Prognostic Biomarker
13%
Tumor Progression
13%
Degree of Differentiation
6%
Advanced Disease
6%
Cell Lining
6%
3D Organization
6%
Epithelial Markers
6%
Prevalent Cancers
6%
N-cadherin Expression
6%
V Protein
6%
Transition Program
6%
Metastatic Carcinoma
6%
Drugable Targets
6%
Squamous Cell
6%
Esophageal Cancer Cells
6%
Reduced Growth
6%
Knockdown
6%
Clinical Significance
6%
Squamous Cell Carcinoma (SqCC)
6%
Negative Regulator
6%
Epithelial Cell Line
6%
Cancer Types
6%
Cell Layer
6%
Overall Survival
6%
China
6%
Gene Knockout
6%
Protein Expression
6%
Drug Development
6%
Gatekeepers
6%
Epithelium
6%
Expression Level
6%
Mouse Intestinal Organoids
6%
Organotypic Model
6%
Inner Wall
6%
Benign Tumor
6%
Hong Kong
6%
Medicine and Dentistry
Esophagus Carcinoma
100%
Mesenchymal-Epithelial Transition
100%
Amyloid Protein
100%
Integrin
66%
Esophageal Squamous Cell Carcinoma
53%
Nerve Cell Adhesion Molecule
40%
Esophagus
33%
Esophageal Squamous Cell Carcinoma Cell Line
20%
Tumor Invasion
20%
Neoplasm
13%
Biological Marker
13%
Epithelial Cell
13%
Cancer Growth Factor
13%
Tumor Progression
13%
Virus Protein V
6%
Squamous Cell
6%
Benign Tumor
6%
Overall Survival
6%
Gene Knockdown
6%
Squamous Cell Carcinoma
6%
Metastatic Carcinoma
6%
Cancer Types
6%
Organoid
6%
Diseases
6%
Epithelial Cell Line
6%
Squamous Cell Carcinoma Cell
6%
Protein Expression
6%
Pharmacology, Toxicology and Pharmaceutical Science
Esophagus Carcinoma
100%
Amyloid Protein
100%
Esophageal Squamous Cell Carcinoma
73%
Integrin
66%
Nerve Cell Adhesion Molecule
40%
Tumor Invasion
20%
Cancer Growth Factor
13%
Neoplasm
13%
Biological Marker
13%
Tumor Growth
13%
Virus Protein V
6%
Benign Neoplasm
6%
Squamous Cell Carcinoma
6%
Malignant Neoplasm
6%
Overall Survival
6%
Drug Development
6%
Diseases
6%